DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lamisil (Terbinafine) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Lamisil (terbinafine hydrochloride) Tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). 

Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis.

DOSAGE AND ADMINISTRATION

Fingernail onychomycosis: One 250 mg tablet once daily for 6 weeks.

Toenail onychomycosis: One 250 mg tablet once daily for 12 weeks.

The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.

DOSAGE FORMS AND STRENGTHS

Tablet, 250 mg white to yellow-tinged white circular, bi-convex, beveled tablets imprinted with “LAMISIL” in circular form on one side and code “250” on the other side.

HOW SUPPLIED/STORAGE AND HANDLING

Lamisil Tablets are supplied as white to yellow-tinged white circular, bi-convex, beveled tablets containing 250 mg of terbinafine imprinted with “LAMISIL” in circular form on one side and code “250” on the other.

Bottles of 100 tablets                                                             NDC 0078-0179-05

Bottles of 30 tablets                                                             NDC 0078-0179-15

Store Lamisil Tablets below 25°C (77°F); in a tight container. Protect from light.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017